Literature DB >> 3956910

[Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].

N Vidon, B Huchet, J C Rambaud.   

Abstract

The effects of a suspension of Saccharomyces boulardii cells on water and sodium secretion induced by cholera toxin was measured in male Wistar rats weighing 220-260 g, using the isolated jejunal loop technique. Concentrations per ml of 3.1 X 10(9), 2.1 X 10(9) and 0.7 X 10(9) viable cells and 3.1 X 10(9) cells killed by irradiation or heating respectively were tested. At this last concentration, the supernatant obtained after centrifugation of the suspension of living cells or of cells killed by irradiation was also tested. Four 10 cm-long loops, the first one beginning at the angle of Treitz, were isolated: the first two loops with and without S. boulardii, the other two (previously incubated with cholera toxin for 3 h) with and without the cells. Each loop contained 1.5 ml of test solution or suspension. S. boulardii living cells had no effect on water and sodium basal intestinal transport but significantly reduced water and sodium secretion induced by cholera toxin within 20 min. Irradiation and heating did not abolish this antisecretory effect while the supernatant obtained after centrifugation of living or irradiated cell suspensions had no inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956910

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  10 in total

1.  Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells.

Authors:  D Czerucka; P Rampal
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.

Authors:  R L Brandão; I M Castro; E A Bambirra; S C Amaral; L G Fietto; M J Tropia; M J Neves; R G Dos Santos; N C Gomes; J R Nicoli
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

3.  Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Authors:  A Qamar; S Aboudola; M Warny; P Michetti; C Pothoulakis; J T LaMont; C P Kelly
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Uptake of yeast (Saccharomyces boulardii) in normal and rotavirus treated intestine.

Authors:  J Cartwright-Shamoon; G R Dickson; J Dodge; K E Carr
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

5.  Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.

Authors:  B Schroeder; C Winckler; K Failing; G Breves
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

6.  Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.

Authors:  Philippe Girard; Yannick Pansart; Ingrid Lorette; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

7.  Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii.

Authors:  J P Buts; P Bernasconi; J P Vaerman; C Dive
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

8.  Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.

Authors:  Johnathan Sheele; Jessica Cartowski; Angela Dart; Arjun Poddar; Shikha Gupta; Eric Stashko; Bhaskara S Ravi; Crawford Nelson; Ajay Gupta
Journal:  Pathog Glob Health       Date:  2015-08-11       Impact factor: 2.894

9.  Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice.

Authors:  S Pecquet; D Guillaumin; C Tancrede; A Andremont
Journal:  Appl Environ Microbiol       Date:  1991-10       Impact factor: 4.792

10.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.